These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 36460821)

  • 1. Pan-cancer analysis based on epigenetic modification explains the value of HJURP in the tumor microenvironment.
    Li J; Zheng J; Zhang R; Zhang W; Zhang J; Zhang Y
    Sci Rep; 2022 Dec; 12(1):20871. PubMed ID: 36460821
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HJURP is a prognostic biomarker for clear cell renal cell carcinoma and is linked to immune infiltration.
    Zhang F; Yuan D; Song J; Chen W; Wang W; Zhu G; Hu B; Chen X; Zhu J
    Int Immunopharmacol; 2021 Oct; 99():107899. PubMed ID: 34217993
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Holliday Cross-Recognition Protein
    Luo D; Liao S; Liu Y; Lin Y; Li Y; Liao X
    Pathol Oncol Res; 2022; 28():1610506. PubMed ID: 35783358
    [No Abstract]   [Full Text] [Related]  

  • 4. The expression level of HJURP has an independent prognostic impact and predicts the sensitivity to radiotherapy in breast cancer.
    Hu Z; Huang G; Sadanandam A; Gu S; Lenburg ME; Pai M; Bayani N; Blakely EA; Gray JW; Mao JH
    Breast Cancer Res; 2010; 12(2):R18. PubMed ID: 20211017
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A pan-cancer analysis of the oncogenic role of Holliday junction recognition protein in human tumors.
    Su R; Huang H; Gao X; Zhou Y; Yin S; Xie H; Zhou L; Zheng S
    Open Med (Wars); 2022; 17(1):317-328. PubMed ID: 35274047
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic value of Holliday junction-recognizing protein and its correlation with immune infiltrates in lung adenocarcinoma.
    Chen L; Zeng C; Yan L; Liao W; Zhen C; Yao J
    Oncol Lett; 2022 Jul; 24(1):232. PubMed ID: 35720487
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MXD3 as an onco-immunological biomarker encompassing the tumor microenvironment, disease staging, prognoses, and therapeutic responses in multiple cancer types.
    Wu SY; Lin KC; Lawal B; Wu ATH; Wu CZ
    Comput Struct Biotechnol J; 2021; 19():4970-4983. PubMed ID: 34584637
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comprehensively prognostic and immunological analysis of actin-related protein 2/3 complex subunit 5 in pan-cancer and identification in hepatocellular carcinoma.
    Huang S; Sun L; Hou P; Liu K; Wu J
    Front Immunol; 2022; 13():944898. PubMed ID: 36148220
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pan-cancer analyses identify MIR210HG overexpression, epigenetic regulation and oncogenic role in human tumors and its interaction with the tumor microenvironment.
    Yadav G; Kulshreshtha R
    Life Sci; 2024 Feb; 339():122438. PubMed ID: 38242493
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LncRNA WAC-AS1 expression in human tumors correlates with immune infiltration and affects prognosis.
    Wang Y; Gong H; Cao Y
    Hereditas; 2023 May; 160(1):26. PubMed ID: 37248547
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Up-Frameshift Suppressor 3 as a prognostic biomarker and correlated with immune infiltrates: A pan-cancer analysis.
    Xu J; Ma H; Shan B
    PLoS One; 2022; 17(10):e0273163. PubMed ID: 36194583
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of Holliday Junction-Recognition Protein-Mediated C-Jun N-Terminal Kinase/ Signal Transducer and Activator of Transcription 3 Signaling Pathway on Cell Proliferation, Cell Cycle and Cell Apoptosis in Bladder Urothelial Carcinoma.
    Gao S; Zhou XQ; Wu Q; Chen XD; Li P; Qin YM
    Tohoku J Exp Med; 2023 Feb; 259(3):209-219. PubMed ID: 36543245
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Holliday junction recognition protein promotes pancreatic cancer growth and metastasis via modulation of the MDM2/p53 signaling.
    Wang CJ; Li X; Shi P; Ding HY; Liu YP; Li T; Lin PP; Wang YS; Zhang GQ; Cao Y
    Cell Death Dis; 2020 May; 11(5):386. PubMed ID: 32439850
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased Expression of Holliday Junction-Recognizing Protein (HJURP) as an Independent Prognostic Biomarker in Advanced-Stage Serous Ovarian Carcinoma.
    Li L; Li X; Meng Q; Khan AQ; Chen X
    Med Sci Monit; 2018 May; 24():3050-3055. PubMed ID: 29743473
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A pan-cancer analysis of RNASEH1, a potential regulator of the tumor microenvironment.
    Yi C; Yang J; Zhang T; Xie S; Li W; Qin L; Chen D
    Clin Transl Oncol; 2023 Aug; 25(8):2569-2586. PubMed ID: 37022517
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multi-omics analysis of N6-methyladenosine reader IGF2BP3 as a promising biomarker in pan-cancer.
    Chen P; Xu J; Cui Z; Wu S; Xie T; Zhang X
    Front Immunol; 2023; 14():1071675. PubMed ID: 36761737
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comprehensive analysis of 33 human cancers reveals clinical implications and immunotherapeutic value of the solute carrier family 35 member A2.
    Xu S; Chen X; Fang J; Chu H; Fang S; Zeng L; Ma H; Zhang T; Chen Y; Wang T; Zhang X; Shen T; Zheng Y; Xu D; Lu Z; Pan Y; Liu Y
    Front Immunol; 2023; 14():1155182. PubMed ID: 37275857
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HJURP inhibits proliferation of ovarian cancer cells by regulating CENP-A/CENP-N.
    Zhang Y; Zhang W; Sun L; Yue Y; Shen D; Tian B; Du M; Dong M; Liu Y; Zhang D
    Bull Cancer; 2022 Oct; 109(10):1007-1016. PubMed ID: 35940943
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advances in holliday junction recognition protein (HJURP): Structure, molecular functions, and roles in cancer.
    Li L; Yuan Q; Chu YM; Jiang HY; Zhao JH; Su Q; Huo DQ; Zhang XF
    Front Cell Dev Biol; 2023; 11():1106638. PubMed ID: 37025176
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SOCS3 Acts as an Onco-immunological Biomarker With Value in Assessing the Tumor Microenvironment, Pathological Staging, Histological Subtypes, Therapeutic Effect, and Prognoses of Several Types of Cancer.
    Dai L; Tao Y; Shi Z; Liang W; Hu W; Xing Z; Zhou S; Guo X; Fu X; Wang X
    Front Oncol; 2022; 12():881801. PubMed ID: 35600392
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.